Abstract

Health Technology Assessment (HTA) is policy research that aims to inform priority setting and resource allocation. HTA is increasingly recognized as a useful policy tool in low- and middle-income countries (LMICs), where there is a substantial need for evidence to guide Universal Health Coverage policies, such as benefit coverage, quality improvement interventions and quality standards, all of which aim at improving the efficiency and equity of the healthcare system. The Health Intervention and Technology Assessment Program (HITAP), Thailand, and the National Institute for Health and Care Excellence (NICE), UK, are national HTA organizations providing technical support to governments in LMICs to build up their priority setting capacity. This paper draws lessons from their capacity building programs in India, Colombia, Myanmar, the Philippines, and Vietnam. Such experiences suggest that it is not only technical capacity, for example analytical techniques for conducting economic evaluation, but also management, coordination and communication capacity that support the generation and use of HTA evidence in the respective settings. The learned lessons may help guide the development of HTA capacity in other LMICs.

Highlights

  • Health technology assessment (HTA) has been widely recognized as a policy tool, which provides helpful information for allocating finite resources and ensures equitable access to needed technologies in the context of universal health coverage (UHC)[1]

  • In many settings where UHC has been adopted as a national policy, policymakers express their concerns about the financial sustainability of the healthcare services and the demand for priority setting tools[11]

  • Limitations of this paper This paper offers a narrative of case studies over a short time period, making it hard to derive conclusions as to the success or failure of the capacity building model we are describing here

Read more

Summary

11 Dec 2017 report report

Health technology assessment, health policy, capacity building, low- and middle-income countries

Introduction
Discussion
Conclusion
World Health Assembly
Singer ME: Cost-effectiveness analysis
13. European Commission
16. Department of Health
28. De Rosas-Valera M
31. Medical Services Administration
38. Perabathina S
40. Maya C
Main text

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.